SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: USP10 deubiquitinates SKP2 and augments the activation of Bcr-Abl by mediating deubiquitination and stabilization of SKP2 in chronic myelogenous leukemia cells [29].